Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). We Can Medicines Co's share price for the quarter that ended in Dec. 2025 was NT$34.4. We Can Medicines Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 45 Mil. Therefore, We Can Medicines Co's market cap for the quarter that ended in Dec. 2025 was NT$1,550 Mil.
We Can Medicines Co's quarterly market cap
declined
from Jun. 2025 (NT$1,525 Mil) to Sep. 2025 (NT$1,354 Mil) but then
increased
from Sep. 2025 (NT$1,354 Mil) to Dec. 2025 (NT$1,550 Mil).
We Can Medicines Co's annual market cap
declined
from Dec. 2023 (NT$4,320 Mil) to Dec. 2024 (NT$1,734 Mil) and
declined
from Dec. 2024 (NT$1,734 Mil) to Dec. 2025 (NT$1,550 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. We Can Medicines Co's Enterprise Value for Today is NT$1,917 Mil.
We Can Medicines Co (ROCO:6929) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
We Can Medicines Co Market Cap Related Terms
We Can Medicines Co Market Cap Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, We Can Medicines Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Market Cap distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
We Can Medicines Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
We Can Medicines Co (ROCO:6929) has a Market Cap of NT$1,005 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on We Can Medicines Co and its competitors. According to the industry distribution chart, We Can Medicines Co ranks #1422 out of 2044 companies in the Consumer Packaged Goods industry, placing it in the top 69.6%.
Is We Can Medicines Co's Market Cap too high?
We Can Medicines Co's current Market Cap is NT$1,005 Mil. Based on the distribution chart, We Can Medicines Co ranks #1422 out of 2044 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #1422 out of 2044 companies for Market Cap. This places We Can Medicines Co in the lower half of its industry. The industry median Market Cap is 103.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 103.12, based on 2,044 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 103.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current Market Cap is NT$1,005 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current Market Cap is NT$1,005 Mil. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current Market Cap is NT$1,005 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
Market Cap: NT$1,005 Mil
GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
